Stock INNOCOLL HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Innocoll Holdings PLC Nasdaq

Equities

US45780Q1031

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Innocoll Holdings PLC
2017 Innocoll : Gurnet Point Capital nears deal to acquire drugmaker Innocoll -sources RE

Managers

Managers TitleAgeSince
Kimball Hall CEO
 Chief Executive Officer 58 23-01-25
Mark Uhle DFI
 Director of Finance/CFO - -
Rebecca Bedno CMP
 Compliance Officer - -
Gwendolyn Niebler CTO
 Chief Tech/Sci/R&D Officer - -
David Arvan PRN
 Corporate Officer/Principal - -
Robert Sklans HRO
 Human Resources Officer - -
Turlough O'Connor AUD
 Comptroller/Controller/Auditor - 05-01-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 30,120,931 20,494,442 ( 68.04 %) 25,000 ( 0.0830 %) 68.04 %

Company contact information

Innocoll Holdings Plc

Monksland Business Park Unit 9, Block D

, Athlone

+353 9 064 86834

http://www.innocoll.com
address Innocoll Holdings PLC

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Company Innocoll Holdings PLC